While CYP2J2 overexpression has shown beneficial effects on vasodilation, inflammation, and contractile recovery from cardiac ischemia, the relevance of CYP2J2 metabolism in CRH had not been previously explored. The gene discussed is CYP2J2; the disease is myocardial ischemia.